FDA approves Levaquin for plague
On April 27, the U.S. Food and Drug Administration approved Levaquin (levofloxacin) to treat patients with plague. The drug was approved under the agency’s…
News
FDA approves expanded use of Prevnar vaccine
The U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50 years and…
FDA approves single REMS for transmucosal immediate-release fentanyl products
The U.S. Food and Drug Administration has approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for transmucosal immediate-release fentanyl (TIRF) products. This…
FDA launches new website on safe disposal of ‘sharps’
The U.S. Food and Drug Administration has launched a new website for patients and caregivers on the safe disposal of needles and other “sharps”…
FDA approves first drug for myelofibrosis
The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease myelofibrosis. Read…
FDA approves first generic version of Lipitor
The U.S. Food and Drug administration has approved the first generic version of Lipitor (atorvastatin calcium). Read more.
FDA approves first combination tablet to treat type 2 diabetes and high cholesterol
The U.S. Food and Drug Administration has approved Juvisync (sitagliptin and simvastatin), the first combination drug to treat type 2 diabetes and high cholesterol…
OTC asthma inhalers with CFCs will not be available after 2011
The U.S. Food and Drug Administration has announced that over-the-counter (OTC) asthma inhalers containing chloroflouorocarbons (CFCs) will no longer be made or sold after…
FDA adds to boxed warning for tumor necrosis factor-alpha blockers
The U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from Legionella and…
FDA approves treatment for hereditary angioedema
The U.S. Food and Drug Administration (FDA) has approved Firazyr (icatibant) Injection for the treatment of acute attacks of hereditary angioedema in people ages…
FDA approves treatment of non-small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved Xalkori (crizotinib) to treat patients with late-stage non-small cell lung cancers who express the abnormal…
FDA publishes REMS list
Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..
FDA approves Levaquin for plague
On April 27, the U.S. Food and Drug Administration approved Levaquin (levofloxacin) to treat patients with plague. The drug was approved under…
FDA approves expanded use of Prevnar vaccine
The U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50…
FDA approves single REMS for transmucosal immediate-release fentanyl products
The U.S. Food and Drug Administration has approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for transmucosal immediate-release fentanyl (TIRF)…
FDA launches new website on safe disposal of ‘sharps’
The U.S. Food and Drug Administration has launched a new website for patients and caregivers on the safe disposal of needles and…
FDA approves first drug for myelofibrosis
The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease…
FDA approves first generic version of Lipitor
The U.S. Food and Drug administration has approved the first generic version of Lipitor (atorvastatin calcium). Read more.
FDA approves first combination tablet to treat type 2 diabetes and high cholesterol
The U.S. Food and Drug Administration has approved Juvisync (sitagliptin and simvastatin), the first combination drug to treat type 2 diabetes and…
OTC asthma inhalers with CFCs will not be available after 2011
The U.S. Food and Drug Administration has announced that over-the-counter (OTC) asthma inhalers containing chloroflouorocarbons (CFCs) will no longer be made or…
FDA adds to boxed warning for tumor necrosis factor-alpha blockers
The U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from…
FDA approves treatment for hereditary angioedema
The U.S. Food and Drug Administration (FDA) has approved Firazyr (icatibant) Injection for the treatment of acute attacks of hereditary angioedema in…
FDA approves treatment of non-small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved Xalkori (crizotinib) to treat patients with late-stage non-small cell lung cancers who express…
FDA publishes REMS list
Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.